Chanel-backed biotech firm raises $120m

Evolved By Nature, a biotech firm backed by French fashion company Chanel, says it has raised $120m in a financing round, adding new investors including one of Canada’s biggest pension funds.

The Massachusetts-based firm plans to use the funding to step up production of a silk protein alternative to petrochemicals in skincare and fabrics.

Evolved By Nature bills its “activated silk” product as natural protein from silkworm cocoons, in liquid form.

Fashion companies are scrambling to meet UN sustainable development goals, according to a report by Business of Fashion.

Evolved By Nature makes biodegradable coatings used in luxury handbags and fast fashion apparel including sports bras and underwear, selling to leather tanneries, fabric mills and fashion labels. The coatings are expected to generate 30% of its sales by the end of 2024. Coatings on leather serve as waterproofing, while treatments for polyester and nylon serve to wick moisture.

“The consumer is catching on to petrochemical-free skincare,” Greg Altman, CEO of Evolved By Nature, said. “We went after the largest-volume fabric produced

— and how do we get chemical coatings off of the fabric,” he said, explaining the focus on polyester and nylon.

While tanners and brands in the leather industry are jointly seeking to develop natural products, they can be a harder sell to the textiles industry, he said.

“In textiles, the conversation is about performance and price and not about sustainability,” he said. “We have to price competitively to petrochemicals.”

On skincare, which will make up the bulk of revenues, the company plans to develop products to sell directly to consumers later in 2022, in addition to sales to large consumer products groups, Altman said.